Humana Inc vs Invesco S&P 500 Low Volatility ETF — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Invesco S&P 500 Low Volatility ETF trades at $72.14 (market cap $6.94B). The key difference: Humana Inc is far larger — about 6.7× Invesco S&P 500 Low Volatility ETF's market cap, and Humana Inc pays a 0.91% dividend while Invesco S&P 500 Low Volatility ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Invesco S&P 500 Low Volatility ETF for 123 Days on average.
| HUM | SPLV | |
|---|---|---|
Market Cap | $46.49B | $6.94B |
Volume | 2,567,704 | 1,663,703 |
Sector | Health | — |
52-Week High | $409.85 | $77.97 |
52-Week Low | $163.67 | $70.30 |
Typical Hold Time | 51 Days | 123 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
SPLV, the Invesco S&P 500 Low Volatility ETF, trades at $72.14 with a 1.29% daily gain, though technical indicators show a bearish trend with moving averages signaling caution. The ETF's sector allocation to Utilities, Real Estate, and Financials has contributed to underperformance relative to the broader S&P 500, with a 5% return versus 17% for the index. Recent dividend distributions of $0.14 per share provide income support amid market volatility.
The outlook remains neutral with valuation concerns at a 19.5x P/E ratio creating headwinds, while geopolitical tensions and sector-specific risks pose challenges. Opportunities exist for investors seeking stability during market uncertainty, though growth potential appears limited compared to broader market ETFs. Key risks include continued sector underperformance and macroeconomic pressures on defensive holdings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →